A clearly defined and followed FDA regulatory strategy is a critical part of the concept rationalization for any medical product. Knowing the difference between what is possible to achieve, difficult to achieve, or not possible to achieve, has direct and significant impact on the device design and materials selection process. Determining resource needs and allocation of those resources can not be done without information regarding the regulatory pathway the product will traverse.

Buckman Company, Inc. has significant experience working with start up companies as well as established companies exploring new product lines. We take pride in our ability to be flexible, responsive, available and creative in working with our clients to build a strategic plan that fits their corporate philosophy, resources and product area.